These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23810915)

  • 1. PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.
    Kunzmann AT; Murray LJ; Cardwell CR; McShane CM; McMenamin UC; Cantwell MM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1490-7. PubMed ID: 23810915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.
    Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y
    Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
    Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
    BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.
    Spence AD; Trainor J; McMenamin Ú; Turkington RC; McQuaid S; Bingham V; James J; Salto-Tellez M; McManus DT; Johnston BT; Cardwell CR; Coleman HG
    Histopathology; 2019 Mar; 74(4):587-596. PubMed ID: 30408225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
    Peng L; Zhou Y; Wang Y; Mou H; Zhao Q
    PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of aspirin-guided therapy of colorectal cancer.
    Mädge JC; Stallmach A; Kleebusch L; Schlattmann P
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1407-1417. PubMed ID: 35171329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
    Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.
    Ye D; Jiang D; Li Y; Jin M; Chen K
    Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.
    Gray RT; Cantwell MM; Coleman HG; Loughrey MB; Bankhead P; McQuaid S; O'Neill RF; Arthur K; Bingham V; McGready C; Gavin AT; Cardwell CR; Johnston BT; James JA; Hamilton PW; Salto-Tellez M; Murray LJ
    Clin Transl Gastroenterol; 2017 Apr; 8(4):e91. PubMed ID: 28448072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 16. Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients.
    Jia H; Wang Z
    Cell Physiol Biochem; 2016; 38(1):122-8. PubMed ID: 26741140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.
    Kim JG; Chae YS; Sohn SK; Moon JH; Ryoo HM; Bae SH; Kum Y; Jeon SW; Lim KH; Kang BM; Park IJ; Choi GS; Jun SH
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):953-60. PubMed ID: 19219602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis.
    Rahbari NN; Bork U; Motschall E; Thorlund K; Büchler MW; Koch M; Weitz J
    J Clin Oncol; 2012 Jan; 30(1):60-70. PubMed ID: 22124103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workload and surgeon's specialty for outcome after colorectal cancer surgery.
    Archampong D; Borowski D; Wille-Jørgensen P; Iversen LH
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005391. PubMed ID: 22419309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.